
EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. The company's integrated sensor utilizes Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes. Used worldwide in hospitals, rehab and skilled nursing facilities, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls and pressure ulcers. EarlySense's offering for consumers includes EarlySense Live and EarlySense Percept. The former is the first at-home consumer health monitor powered by EarlySense's medically-proven sensor and AI analytics. It is particularly useful for tracking the health and sleep of the aging population and children, to help facilitate better health choices. EarlySense Percept, on the other hand, is the first clinically-proven contactless monitor for fertility and period tracking. It accurately tracks internal body signals and assists couples who are trying to conceive. EarlySense has partnered with leading global technology companies including Samsung, Welch Allyn, iFit and Beurer.
Primary contact Woburn, Massachusetts, United States
Funding 💰
Total $145M
Select investors Samsung Ventures, Pitango Venture Capital,
Hill-Rom, JK&B Capital, ProSeed Venture Capital Fund,
Welch Allyn, Noaber Foundation, Bridge Investment Fund
Last update: October 9, 2020